SCHEMBL7970971

SCHEMBL7970971

CCOCCOc1ccc(C(=O)c2c(-c3ccc(OC)cc3)sc3cc(OC)ccc23)cc1.COc1ccc(-c2sc3cc(OC)ccc3c2C(=O)c2ccc(O)cc2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 19/20 0.68
ESR2 Q92731 11/20 0.68
MEN1 O00255 2/20 0.57
ALDH1A1 P00352 2/20 0.57
LMNA P02545 2/20 0.57
TP53 P04637 2/20 0.57
CYP3A4 P08684 2/20 0.57
MAPT P10636 2/20 0.57
ALOX15 P16050 2/20 0.57
KMT2A Q03164 2/20 0.57
HSD17B10 Q99714 2/20 0.57
TDP1 Q9NUW8 2/20 0.57
PLD2 O14939 1/20 0.57
KDM1A O60341 1/20 0.57
NR1I2 O75469 1/20 0.57
USP2 O75604 1/20 0.57
C5 P01031 1/20 0.57
FYN P06241 1/20 0.57
PGR P06401 1/20 0.57
ADRA2A P08913 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7971665 0.98 ESR1 (0.66) ESR1ESR2MEN1ALDH1A1LMNA
SCHEMBL8082359 0.96 ESR1 (0.68) ESR1ESR2CNR1TUBB4ATUBB
SCHEMBL8082459 0.92 ESR1 (0.68) ESR1ESR2MEN1ALDH1A1LMNA
SCHEMBL11549428 0.90 ESR1 (0.73) ESR1ESR2MEN1ALDH1A1LMNA
SCHEMBL11546753 0.90 ESR1 (0.69) ESR1ESR2MEN1ALDH1A1LMNA
SCHEMBL16380497 0.89 ESR1 (0.67) ESR1ESR2CNR1TUBB4ATUBB
SCHEMBL16347638 0.89 ESR1 (0.66) ESR1ESR2MEN1ALDH1A1LMNA
SCHEMBL16345819 0.89 ESR1 (0.66) ESR1ESR2MEN1ALDH1A1LMNA
SCHEMBL11552962 0.88 ESR1 (0.72) ESR1ESR2MEN1ALDH1A1LMNA
SCHEMBL1665792 0.87 CNR1 (0.70) ESR1ESR2MEN1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6291484-B1 TREATMENT OF THE VARIOUS MEDICAL CONDITIONS ASSOCIATED WITH POSTMENOPAUSAL SYNDROME ELI LILLY AND COMPANY 2001-09-18 US disclosed
EP-0902025-A2 Benzothiophenes for treatment of estrogen related conditions ELI LILLY AND COMPANY (US) 1999-03-17 EP disclosed